← Silence Therapeutics plc

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $244k $5.5m $12.4m $17.5m $25.4m $43.3m $559k
Cost of Revenue $121k $3.8m $7.5m $10.9m $10.3m $11.8m $215k
Cost of sales — ($3.8m) ($7.5m) ($10.9m) ($10.3m) — —
Reconciled Cost Of Revenue — — — — — $11.8m $215k
Gross Profit $244k $1.7m $5.0m $6.6m $15.1m $31.4m $344k
Research And Development — — — — — $67.9m $67.8m
Operating expenses:
Operating Income (Loss) ($22.7m) ($35.8m) ($45.8m) ($48.6m) ($49.6m) ($63.3m) ($91.1m)
Additional Financial Items
Applicable Tax Rate $0 $0 $0 $0 $0 — —
Finance Income $27k $129k $10k $1.3m $1.4m — —
Foreign Currency Transaction Gain (Loss), before Tax — — — — — $646k ($8.5m)
Goodwill, Impairment Loss — — — — — $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — ($89.7m)
Other Income — — — — — $4.5m $3.5m
Profit Loss Before Tax ($22.9m) ($36.0m) ($45.9m) ($47.4m) ($50.3m) — —
Profit Loss From Operating Activities ($22.7m) ($35.8m) ($45.8m) ($48.6m) ($49.6m) ($63.3m) ($91.1m)
Finance and other income $27k $129k $10k $1.3m $1.4m — —
Loss for the year before taxation ($22.9m) ($36.0m) ($45.9m) ($47.4m) ($50.3m) — —
Taxation $3.3m $3.5m $6.4m $6.9m $7.0m — —
Loss for the year after taxation ($19.6m) ($32.5m) ($39.4m) ($40.5m) ($43.3m) — —
Diluted EPS — — — — — ($0.99) ($1.89)
Diluted NI Availto Com Stockholders — — — — — ($45.3m) ($88.6m)
Gain On Sale Of Security — — — — — $646k ($8.5m)
Interest Income — — — — — $4.5m $3.5m
Interest Income Non Operating — — — — — $4.5m $3.5m
Net Income From Continuing And Discontinued Operation — — — — — ($45.3m) ($88.6m)
Net Income From Continuing Operation Net Minority Interest — — — — — ($45.3m) ($88.6m)
Net Interest Income — — — — — $4.5m $3.5m
Normalized EBITDA — — — — — ($63.4m) ($79.4m)
Normalized Income — — — — — ($45.8m) ($81.3m)
Other Gand A — — — — — $26.9m $22.3m
Reconciled Depreciation — — — — — $593k $555k
Restructuring And Mergern Acquisition — — — — — $0 $1.3m
Selling General And Administration — — — — — $26.9m $22.3m
Special Income Charges — — — — — $0 ($1.3m)
Tax Effect Of Unusual Items — — — — — $162k ($2.4m)
Tax Provision — — — — — $845k $11k
Tax Rate For Calcs — — — — — $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — — — — ($44.5m) ($88.6m)
Net Foreign Exchange Loss $130k $307k $44k — $2.1m — —
Total Unusual Items — — — — — $646k ($9.8m)
Total Unusual Items Excluding Goodwill — — — — — $646k ($9.8m)
Pre-Tax Income — — — — — ($44.5m) ($88.6m)
Net Income Continuous Operations — — — — — ($45.3m) ($88.6m)
Net Income (Loss) Attributable to Parent — — — — — ($45.3m) ($88.6m)
Net Income Including Noncontrolling Interests — — — — — ($45.3m) ($88.6m)
Earnings Per Share, Basic — — — — — ($0.33) ($0.63)
Earnings Per Share, Diluted — — — — — ($0.33) ($0.63)
Weighted Average Number of Shares Outstanding, Basic — — — — — 138.8m 141.7m
Basic Average Shares — — — — — $46.3m $47.2m
Diluted Average Shares — — — — — $46.3m $47.2m
Weighted Average Number of Shares Outstanding, Diluted — — — — — 138.8m 141.7m
Research and Development Expense $13.3m $20.2m $30.8m $35.6m $44.0m $67.9m $67.8m
Research and development costs ($13.3m) ($20.2m) ($30.8m) ($35.6m) ($44.0m) — —
General and Administrative Expense — — $20.0m $19.6m $20.6m $26.9m $22.3m
General and administrative expenses ($9.6m) ($14.0m) ($20.0m) ($19.6m) ($20.6m) — —
Administrative Expense $9.6m $14.0m — — — — —
Current Tax Expense (Income) — — ($6.4m) ($7.3m) ($7.0m) — —
Deferred Tax Expense (Income) — — $0 $0 $0 — —
Employee Benefits Expense $7.2m $12.1m $21.3m $26.9m $30.4m — —
Expense From Share-Based Payment Transactions With Employees $584k $4.4m $8.6m $10.3m $13.1m — —
Finance Costs $163k $323k $52k $47k $2.2m — —
Finance and other expenses ($163k) ($323k) ($52k) ($47k) ($2.2m) — —
Interest Expense On Lease Liabilities $33k $16k $8k $47k $34k — —
Current Income Tax Expense (Benefit) — — — — — $845k $11k
Income Tax Expense Continuing Operations ($3.3m) ($3.5m) ($6.4m) ($6.9m) ($7.0m) — —
Interest Expense — — $11k $57k $43k — —
Interest Expense Non Operating — — $11k $57k $43k — —
Net Non Operating Interest Income Expense — — — — — $4.5m $3.5m
Operating Expense — — — — — $94.8m $90.1m
Other Income Expense — — — — — $14.4m ($2.3m)
Other Non Operating Income Expenses — — — — — $13.7m $7.5m
Rent Expense Supplemental — — $448k $410k — — —
Income Tax Expense (Benefit) — — — — — $845k $11k
Total Expenses — — — — — $106.6m $90.3m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.